Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RPT CRUSH relative bioavailability study
PACTR202306775627089Phase 1Completed
- Sponsor
- Stellenbosch University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of rifapentine and isoniazid in Tuberculosis (TB) and latent tuberculosis infection (LTBI) (3 arms), sponsored by Stellenbosch University. Started Jan 2023; status: completed.
02
Drugs
rifapentineisoniazid
03
Conditions
Tuberculosis (TB)latent tuberculosis infection (LTBI)
Beyond the preview
Go deeper on PACTR202306775627089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202306775627089.